Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03218293 : Thrombolysis and RIPC in Acute Ischemic Stroke
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- In accordance with the Guideline of Thrombolysis in Acute Ischemic Stroke and
accomplish intravenous thrombolytic therapy using alteplase;

- The consciousness of patients are conscious,somnolence,confusion and stupor?can comply
better with the RIPC treatment;

- Acute ischemic stroke confirmed by cranial CT/MRI;

- Provision of written informed consent.

Exclusion criteria:

- History of cerebral embolism,cerebral hemorrhage, brain tumor, brain trauma or other
brain lesion;

- Severe cardiac, liver, or kidney disease, malignancy, systemic organ dysfunction;

- Blood pressure <90/60 mmHg or >200/110 mmHg after treatment;

- Dementia or mental illness;

- History of major surgery or trauma 4 weeks prior to admission;

- Failure to provide informed consent.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03218293      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740